divendres, 20 de juny del 2014

mHealth: Ideomed dodges FDA review for Abriiz medical app




FDA regulators assure Ideomed that the company's Abriiz app won't need formal regulatory review under the FDA's mobile medical device "enforcement discretion" process.





mHealth: Ideomed's medical app gets a pass from the FDA

Michigan medical app maker Ideomed will get to dodge FDA review for its medical app, allowing the company to save a lot of time and money in reaching a larger audience.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1w4caHl

Cap comentari:

Publica un comentari a l'entrada